Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avery August

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature Immunology|January 16, 2019
Thymic regulatory T cells arise via two distinct developmental programsDavid L Owen, Shawn A Mahmud, Louisa E Sjaastad, et al.
NPJ Vaccines|December 17, 2022
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola virusesDuncan G Ithinji, David W Buchholz, Shahrzad Ezzatpour, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Cell|June 9, 2023
Juneteenth in STEMM and the barriers to equitable scienceAlfred Mays, Angela Byars-Winston, Antentor Hinton, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature Immunology|January 16, 2019
Thymic regulatory T cells arise via two distinct developmental programsDavid L Owen, Shawn A Mahmud, Louisa E Sjaastad, et al.
NPJ Vaccines|December 17, 2022
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola virusesDuncan G Ithinji, David W Buchholz, Shahrzad Ezzatpour, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Cell|June 9, 2023
Juneteenth in STEMM and the barriers to equitable scienceAlfred Mays, Angela Byars-Winston, Antentor Hinton, et al.
Pageof 15